📰 7 sources covering this story

Cancer patient becomes world’s first to receive ‘landmark’ treatment

First covered 2 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Cancer patient becomes world’s first to receive ‘landmark’ treatment
Cancer patient becomes world’s first to receive ‘landmark’ treatment
Tracy Tomlinson, 58, was given the drug at the Christie NHS Foundation Trust in Manchester as part of a clinical trial evaluating a new type of treatment for several types of cancer
The Age
The Age1 hrs ago
Clinical trial based on Richard Scolyer’s treatment offers new hope for brain cancer patients
It is hoped this pioneering approach to brain cancer will have benefits for patients around the world.
Clinical trial based on Richard Scolyer’s treatment offers new hope for brain cancer patients
It is hoped this pioneering approach to brain cancer will have benefits for patients around the world.
Sky News Tech
Sky News Tech10 hrs ago
Cancer patient becomes first to receive 'landmark' treatment
A woman with advanced ovarian cancer has become the first patient in the world to receive a pioneering new therapy, in what is being hailed as a "landmark moment".
The Mirror
The Mirror18 hrs ago
Lung cancer patient becomes first in the world to receive a new vaccine - after personal trauma
Chris Jones, from the Wirral, Merseyside, is the first person in the world to be treated as part of the early-stage clinical trial designed to improve the treatment of some forms of advanced lung cancer
Israeli scientists launch world-first clinical trial for experimental pancreatic cancer treatment
The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.
South China Morning Post
South China Morning Post🏁 first to report2 days ago
Hong Kong drives trials for breast cancer, eye treatments across Greater Bay Area
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health Hope Pharma found